| View |
DR-XY43376_PI_01.pdf
|
DR-XY43376
|
Ruxolitinib (as phosphate)
|
Jakavi
|
5 mg
|
Tablet
|
-
|
Novartis Pharma Stein AG
|
Switzerland
|
Initial (Variation)
|
05 May 2023
|
05 May 2028
|
| View |
DR-XY43377_PI_01.pdf
|
DR-XY43377
|
Ruxolitinib (As Phosphate)
|
Jakavi
|
15 mg
|
Tablet
|
-
|
Novartis Pharma Stein AG
|
Switzerland
|
Initial (Variation)
|
08 February 2023
|
08 February 2028
|
| View |
DR-XY43378_PI_01.pdf
|
DR-XY43378
|
Ruxolitinib (As Phosphate)
|
Jakavi
|
20 mg
|
Tablet
|
Protein Kinase Inhibitor
|
Novartis Pharma Stein AG
|
Switzerland
|
Initial (Variation)
|
08 February 2023
|
08 February 2028
|
| View |
|
DR-XY43385
|
Donepezil Hydrochloride
|
Servonex
|
10 mg
|
Film-Coated Tablet
|
Cholinesterase Inhibitor
|
Kusum Healthcare Private Limited
|
India
|
Renewal
|
06 December 2023
|
09 May 2029
|
| View |
|
DR-XY43391
|
Fexofenadine Hydrochloride
|
Fenofex
|
180 mg
|
Film-Coated Tablet
|
Antihistamine
|
Geofman Pharmaceuticals
|
Pakistan
|
Renewal
|
01 April 2024
|
07 May 2029
|
| View |
|
DR-XY43392
|
Atorvastatin (As Calcium) + Amlodipine (As Besilate)
|
Atstat AM
|
10 mg/5 mg
|
Film-Coated Tablet
|
-
|
Ind-Swift Limited (Global Business Unit)
|
India
|
-
|
31 March 2021
|
07 May 2026
|
| View |
|
DR-XY43399
|
Irbesartan
|
Irbezil
|
300mg
|
Film-Coated Tablet
|
-
|
Aurochem Laboratories
|
India
|
-
|
14 February 2020
|
26 November 2024
|
| View |
|
DR-XY43405
|
Simvastatin
|
Unbranded
|
40 mg
|
Film-Coated Tablet
|
Antihypercholesterolemina
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
17 January 2024
|
19 May 2029
|
| View |
|
DR-XY43406
|
Simvastatin
|
Unbranded
|
20 mg
|
Film-Coated Tablet
|
Antihypercholesterolemina
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 January 2024
|
19 May 2029
|
| View |
|
DR-XY43409
|
Ascorbic Acid + Zinc (as sulfate monohydrate)
|
Unbranded
|
500 mg/10 mg
|
Film-coated tablet
|
Vitamin and Mineral
|
Amherst Laboratories Inc.
|
Philippines
|
Renewal
|
17 April 2024
|
18 June 2029
|
| View |
|
DR-XY43410
|
OMEPRAZOLE
|
OMEGUT
|
40mg
|
Powder for Injection (I.V)
|
PROTON PUMP INHIBITOR
|
Popular Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
29 May 2024
|
13 May 2029
|
| View |
|
DR-XY43422
|
Salbutamol (as Sulfate)
|
Vimonzil
|
2mg/5mL
|
Oral Solution
|
Bronchodilator
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
02 January 2024
|
20 May 2029
|
| View |
|
DR-XY43433
|
TOBRAMYCIN + DEXAMETHASONE (AS SODIUM PHOSPHATE)
|
ORBITEX T
|
3mg/1mg permL (0.3%/ 0.1% w/v)
|
Sterile Ophthalmic Solution (Eye Drops)
|
ANTI-INFECTIVE
|
Popular Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
10 May 2024
|
20 May 2029
|
| View |
|
DR-XY43438
|
Gabapentin
|
Epiven
|
300 mg
|
Capsule
|
Anticonvulsant
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
22 January 2024
|
20 May 2029
|
| View |
DR-XY43444_PIL_01.pdf
|
DR-XY43444
|
Ferrous Sulfate + Folic Acid
|
Anifer
|
60 mg/400 mcg
|
Film Coated Tablet
|
Vitamin/Mineral
|
San Marino Laboratories Corporation
|
Philippines
|
Renewal
|
26 May 2022
|
08 July 2027
|
| View |
|
DR-XY43447
|
Celecoxib
|
Occib
|
200 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 February 2024
|
27 May 2029
|
| View |
|
DR-XY43450
|
Celecoxib
|
Occib
|
400 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
05 February 2024
|
29 May 2029
|
| View |
|
DR-XY43451
|
Celecoxib
|
Coxcel
|
400 mg
|
Capsule
|
Selective COX-2 Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
24 January 2024
|
29 May 2029
|
| View |
|
DR-XY43453
|
Multivitamins + Minerals
|
Berocca Performance
|
(see reverse for formulation)
|
Effervescent Tablet
|
Vitamins and Minerals
|
PT. Bayer Indonesia
|
Indonesia
|
Renewal
|
10 March 2024
|
30 May 2029
|
| View |
|
DR-XY43465
|
Lidocaine + Prilocaine
|
Combikane
|
25 mg/25 mg per g
|
Cream
|
Local Anesthetic
|
Yash Medicare Pvt. Ltd.
|
India
|
Renewal
|
08 April 2024
|
03 June 2029
|